Capital Research Global Investors Takeda Pharmaceutical CO LTD Transaction History
Capital Research Global Investors
- $443 Billion
- Q2 2024
A detailed history of Capital Research Global Investors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Capital Research Global Investors holds 13,126,608 shares of TAK stock, worth $191 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,126,608
Previous 13,121,930
0.04%
Holding current value
$191 Million
Previous $182 Million
6.81%
% of portfolio
0.04%
Previous 0.04%
Shares
14 transactions
Others Institutions Holding TAK
# of Institutions
318Shares Held
70.4MCall Options Held
939KPut Options Held
233K-
Mondrian Investment Partners LTD London, X07.74MShares$113 Million1.74% of portfolio
-
Morgan Stanley New York, NY4.99MShares$72.5 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$63.2 Million0.03% of portfolio
-
Goldman Sachs Group Inc New York, NY3.72MShares$54.1 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.95MShares$43 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...